U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07803432) titled 'Creating Stem Cells From a Progeria Patient's Blood to Test Candidate Treatments in the Lab' on Aug. 31.
Brief Summary: This study aims to establish induced pluripotent stem cell (iPSC) lines from the blood of one pediatric patient with Hutchinson-Gilford Progeria Syndrome (HGPS), a rare disease that causes rapid, premature aging, in order to build a laboratory model of the disease. The main purpose of this study is to collect a blood sample (a total of 9cc, drawn once) from the patient, reprogram the patient's blood cells into stem cells, and then differentiate these stem cells into disease-relevant cell types (such as fibroblasts,...